Inventor · disambiguated record
Colin Powers
Also filed as: POWERS COLIN
12 granted patents·14 pending applications·87 citations·filing 2012–2025
90Inventor score
Files withSALK INST FOR BIOLOGICAL STUDI22BIOMATRICA INC1SCIENCE UNIVERSITY OREGON HEALTH AND1SORRENTO THERAPEUTICS INC1UNIV OREGON HEALTH & SCIENCE1
Top patents by PatentIndex Score
26 records- 0196US12281324B2Exogenous gene expression in recombinant adenovirus for minimal impact on viral kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2022·Granted Apr 22, 2025·2 cites·35 claims
- 0296US10101329B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2016·Granted Oct 16, 2018·9 cites·46 claims
- 0395US11401529B2Exogenous gene expression in recombinant adenovirus for minimal impact on viral kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2020·Granted Aug 2, 2022·3 cites·67 claims
- 0495US10738325B2Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted Aug 11, 2020·10 cites·20 claims
- 0592US9217160B2Adenoviral assembly methodSALK INST FOR BIOLOGICAL STUDI·Filed 2013·Granted Dec 22, 2015·13 cites·20 claims
- 0691US9913866B2Selective cell targeting using adenovirus and chemical dimersSALK INST FOR BIOLOGICAL STUDI·Filed 2014·Granted Mar 13, 2018·25 cites·10 claims
- 0791US9885090B2Adenoviral tumor diagnosticsSALK INST FOR BIOLOGICAL STUDI·Filed 2014·Granted Feb 6, 2018·9 cites·18 claims
- 0888US11130968B2High throughput assay for measuring adenovirus replication kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted Sep 28, 2021·3 cites·21 claims
- 0987US10577589B2Adenoviral assembly methodSALK INST FOR BIOLOGICAL STUDI·Filed 2015·Granted Mar 3, 2020·3 cites·15 claims
- 1086US9187733B2Anti-cancer adenovirusesSALK INST FOR BIOLOGICAL STUDI·Filed 2013·Granted Nov 17, 2015·10 cites·9 claims
- 1183US2025146013A1High throughput assay for measuring adenovirus replication kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2024·Application pending·0 cites
- 1279US2024342231A1Selective cell targeting using adenovirus and chemical dimersSALK INST FOR BIOLOGICAL STUDI·Filed 2024·Application pending·0 cites
- 1378US2025382638A1Exogenous gene expression in recombinant adenovirus for minimal impact on viral kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2025·Application pending·0 cites
- 1478US2024207445A1Tumor-targeting synthetic adenoviruses and uses thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2023·Application pending·0 cites
- 1575US2022411763A1Adenoviral assembly methodSALK INST FOR BIOLOGICAL STUDI·Filed 2022·Application pending·0 cites
- 1672US2023364263A1Synthetic adenoviruses targeting bone tissue and uses thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2023·Application pending·0 cites
- 1770US11813337B2Tumor-targeting synthetic adenoviruses and uses thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2019·Granted Nov 14, 2023·0 cites·24 claims
- 1870US2022090123A1High throughput assay for measuring adenovirus replication kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2021·Application pending·0 cites
- 1968US2020149014A1Adenoviral assembly methodSALK INST FOR BIOLOGICAL STUDI·Filed 2020·Application pending·0 cites
- 2062US2013142823A1Cmv glycoproteins and recombinant vectorsSCIENCE UNIVERSITY OREGON HEALTH AND·Filed 2012·Application pending·0 cites
- 2160US2019314525A1Synthetic adenoviruses targeting bone tissue and uses thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2019·Application pending·0 cites
- 2259US2023357793A1Oncolytic herpes simplex viruses (hsv) expressing immunomodulatory fusion proteinsSORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2358US2018100204A1Adenoviral tumor diagnosticsSALK INST FOR BIOLOGICAL STUDI·Filed 2017·Application pending·0 cites
- 2454US11730781B2Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regenerationSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted Aug 22, 2023·0 cites·11 claims
- 2552US2018147245A1Selective cell targeting using adenovirus and chemical dimersSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Application pending·0 cites
- 2641US2018363026A1Stabilization of pcr reagents and assaysBIOMATRICA INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Colin Powers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →